A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
Authors
Keywords
Fenretinide, Bioavailability, Solubility, Antitumour activity, Cancer stem cells, Solid tumours, Drug delivery, Pharmacokinetics, Cancer therapy
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-22
DOI
10.1186/s13046-019-1383-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins
- (2019) Ching-Yun Hsu et al. Nutrients
- A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
- (2019) Isabella Orienti et al. Cell Death & Disease
- Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
- (2019) Maria Laura De Angelis et al. Frontiers in Oncology
- Nanoscale Functional Biomaterials for Cancer Theranostics
- (2018) Linying Liu et al. CURRENT MEDICINAL CHEMISTRY
- Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells
- (2017) L M Fettig et al. ONCOGENE
- Nanomedicine-mediated cancer stem cell therapy
- (2016) Song Shen et al. BIOMATERIALS
- Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma
- (2016) Alexander Roesch et al. EUROPEAN JOURNAL OF CANCER
- Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer
- (2016) Francesca Vulcano et al. EXPERIMENTAL CELL RESEARCH
- Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
- (2016) Abhijit A. Date et al. JOURNAL OF CONTROLLED RELEASE
- Fenretinide targets the side population in myeloma cell line NCI-H929 and potentiates the efficacy of antimyeloma with bortezomib and dexamethasone regimen
- (2016) Wenqing Yan et al. LEUKEMIA RESEARCH
- Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts
- (2016) N. E. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways
- (2016) Gemma Leon et al. PHARMACOLOGY & THERAPEUTICS
- Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
- (2016) Marta Di Martile et al. Oncotarget
- Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
- (2016) Barbara Bassani et al. PLoS One
- Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells
- (2015) Nabanita Mukherjee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer
- (2015) Sara Pignatta et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeting the root of cancer relapse
- (2015) Alexandra Flemming NATURE REVIEWS DRUG DISCOVERY
- Suppression of cancer relapse and metastasis by inhibiting cancer stemness
- (2015) Youzhi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer
- (2015) G Sette et al. Cell Death & Disease
- Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model
- (2015) Sandra Durante et al. Oncotarget
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
- (2014) R Santini et al. ONCOGENE
- Nanocarriers for delivery of platinum anticancer drugs
- (2013) Hardeep S. Oberoi et al. ADVANCED DRUG DELIVERY REVIEWS
- Role of integrated cancer nanomedicine in overcoming drug resistance
- (2013) Arun K. Iyer et al. ADVANCED DRUG DELIVERY REVIEWS
- Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts
- (2013) Giovanni Sette et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium
- (2013) Barry J. Maurer et al. PEDIATRIC BLOOD & CANCER
- C22:0- and C24:0-dihydroceramides Confer Mixed Cytotoxicity in T-Cell Acute Lymphoblastic Leukemia Cell Lines
- (2013) Michael W. Holliday Jr. et al. PLoS One
- Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo
- (2012) H. Xie et al. CARCINOGENESIS
- Influence of Counterions on Micellization of Tetramethylammonium Perfluorononanoic Carboxylate in 1-Butyl-3-methylimidazolium Ionic Liquid
- (2012) Panfeng Long et al. JOURNAL OF PHYSICAL CHEMISTRY B
- EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential
- (2012) Giovanni Sette et al. PLoS One
- Proliferation State and Polo-Like Kinase1 Dependence of Tumorigenic Colon Cancer Cells
- (2012) Federica Francescangeli et al. STEM CELLS
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
- (2012) Hifzur Rahman Siddique et al. STEM CELLS
- Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure
- (2011) Jason P Cooper et al. BRITISH JOURNAL OF PHARMACOLOGY
- Identification of Dihydroceramide Desaturase as a Directin VitroTarget for Fenretinide
- (2011) Mehrdad Rahmaniyan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
- (2008) H. Maeda et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing
- (2008) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update
- (2008) Ekarat Jantratid et al. PHARMACEUTICAL RESEARCH
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started